Effects of High Dose Atrial Natriuretic Peptide on Renal Haemodynamics, Sodium Handling and Hormones in Cirrhotic Patients with and Without Ascites

References

• Henriksen J H, Ring-Larsen H. Ascites formation in liver cirrhosis: the how and the why. Dig Dis 1990; 8: 152–62
   Google Scholar
• Jespersen B, Pedersen E B, Madsen M, Christensen P, Eiskjær H, Leyssac P P. Disturbed relationship between urinary prostaglandin E2 plasma arginine vasopressin and renal water excretion after oral water loading in early hepatic cirrhosis. Eur J Clin Invest 1988; 18: 202–6
   PubMedGoogle Scholar
• Hattori K, Yauchi T, Minato Y, Hasumura Y, Takeuchi J, Shigai T. A lithium clearance study of sodium reabsorption at the proximal tubule in liver cirrhosis with ascites. Gastroenterol Japon 1989; 24: 535–9
   Google Scholar
• Simón M-A, Diez J, Prieto J. Abnormal sympathetic and renal response to sodium restriction in compensated cirrhosis. Gastroenterology 1991; 101: 1354–60
   Google Scholar
• Koomans H A, Boer W H, Dorhout Mees E J. Evaluation of lithium clearance as a marker of proximal tubule sodium handling. Kidney Int 1989; 36: 2–12
   PubMed Web of Science ®Google Scholar
• Awazu M, Ichikawa I. Biological significance of atrial natriuretic peptide in the kidney. Nephron 1993; 63: 1–14
   PubMedGoogle Scholar
• Haynes W G, Webb D J. The endothelin family of peptides: local hormones with diverse roles in health and disease. Clin Sci 1993; 84: 485–500
   PubMed Web of Science ®Google Scholar
• Veglio F, Pinna G, Melchio R, Rabbia F, Panarelli M, Gagliardi B. Plasma endothelin levels in cirrhotic subjects. J Hepatol 1992; 15: 85–7
   PubMed Web of Science ®Google Scholar
• Moore K, Wendon J, Frazer M, Karani J, Williams R, Badr K. Plasma endothelin immunoreactivity in liver disease and the hepatorenal syndrome. N Engl J Med 1992; 327: 1774–8
   PubMed Web of Science ®Google Scholar
• Moreau R, Hadengue A, Pussard E, Soubrane O, Sogni P, Gaudin C. Relationship between plasma atrial natriuretic peptide concentrations and hemodynamics and hematocrit in patients with cirrhosis. Hepatology 1991; 14: 1035–9
   Google Scholar
• Warner L C, Campbell P J, Morali G A, Logan A G, Skorecki K L, Blendis L M. The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease. Hepatology 1990; 12: 460–6
   Google Scholar
• Jespersen B, Jensen L, Sørensen S S, Pedersen E B. Atrial natriuretic factor, cyclic 3′,5′-guanosine monophosphate and prostaglandin E2 in liver cirrhosis: relation to blood volume and changes in blood volume after furosemide. Eur J Clin Invest 1990; 20: 632–41
   PubMedGoogle Scholar
• Jiménez W, Gutkowska J, Ginés P, Arroyo V, Rivera F, Rodés J. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites. Hepatology 1991; 14: 601–7
   Google Scholar
• Salerno F, Badalamenti S, Incerti P L, Capozza L, Mainardi L. Response to atrial natriuretic peptide in patients with advanced cirrhosis. Hepatology 1988; 8: 21–26
   Google Scholar
• Beutler J J, Koomans H A, Rabelink T J, Gaillard C A, Van Hattum J, Boer P. Blunted natriuretic response and low blood pressure after atrial natriuretic factor in early cirrhosis. Hepatology 1989; 10: 148–53
   Google Scholar
• Laffi G, Pinzani M, Meacci E, La Villa G, Renzi D, Baldi E. Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. Gastroenterology 1989; 96: 167–77
   Google Scholar
• Ferrier C, Beretta-Piccoli C, Weidmann P, Gnädinger M P, Shaw S, Suchecka-Rachon K. Hypotension and renal impairment during infusion of atrial natriuretic factor in liver cirrhosis with ascites. Am J Nephrol 1989; 9: 291–9
   Google Scholar
• Petrillo A, Scherrer U, Gonvers J J, Nussberger J, Marder H, De Vane P H. Atrial natriuretic peptide administrated as intravenous infusion or bolus injection to patients with liver cirrhosis and ascites. J Cardiovasc Pharmacol 1988; 12: 279–85
   Google Scholar
• Gluud C. Serum testosterone concentrations in men with alcoholic cirrhosis: background for variation. Metabolism 1987; 36: 373–8
   PubMed Web of Science ®Google Scholar
• Thomassen A, Bagger J P, Nielsen T T, Pedersen E B. Atrial natriuretic peptide during pacing in controls and patients with coronary artery disease. Int J Cardiol 1987; 17: 267–76
   PubMed Web of Science ®Google Scholar
• Sørensen S S. Radio-immunoassay of endothelin in human plasma. Scan J Clin Lab Invest 1991; 51: 615–23
   PubMed Web of Science ®Google Scholar
• Kappelgaard A M, Damkjær-Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Bruusgaard A, Munck O, Nielsen M D, Worming H. The significance of bile acids and aldosterone for the electrical hyperpolarization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974; 9: 417–26
   PubMed Web of Science ®Google Scholar
• Pedersen E B, Danielsen H, Spencer E S. Effect of endapamide on renal plasma flow glomerular filtration rate and arginine vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543–7
   PubMed Web of Science ®Google Scholar
• Hartter E, Woloszczuk W. Radioimmunological determination of arginine vasopressin and human atrial natriuretic peptide after simultaneous extraction from plasma. J Clin Chem Clin Biochem 1986; 24: 559–63
   PubMedGoogle Scholar
• Christensen P, Leyssac P P. A specific radioimmunoassay for PGE2 using an antibody with high specificity and a sephadex LH 20 microcolumn for separation of prostaglandins. Prostaglandins 1976; 11: 399–420
   PubMed Web of Science ®Google Scholar
• Miles D W, Mogensen C E, Gundersen HJG. Radioimmunoassay for urinary albumin using a single antibody. Scand J Clin Lab Invest 1970; 26: 5–11
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Bendtsen F, Schütten H J, Warberg J. Hepatic-intestinal disposal of endogenous human alpha atrial natriuretic factor 99–126 in patients with cirrhosis. Am J Gastroenterol 1990; 85: 1155–9
   Google Scholar
• Vesely D L, Preston R, Winters C J, Rico D M, Sallman A L, Epstein M. Increased release of the N-terminal and C-terminal portions of the atrial natriuretic factor prohormone during immersion-induced central hypervolemia in cirrhotic humans. Am J Nephrol 1991; 11: 207–16
   Google Scholar
• Rector W G, Adair O, Hossack K F, Rainguet S. Atrial volume in cirrhosis: relationship to blood volume and plasma concentration of atrial natriuretic factor. Gastroenterol 1990; 99: 766–70
   PubMed Web of Science ®Google Scholar
• Henriksen J H, Bendtsen F, Gerbes A L, Juel Christensen N, Ring-Larsen H, Sørensen TIA. Estimated central blood volume in cirrhosis: Relationship to sympathetic nervous activity beta-adrenergic blockade and atrial natriuretic factor. Hepatology 1992; 5: 1163–70
   Google Scholar
• Moreau R, Pussard E, Brenard R, Gaudin C, Berdeaux A, Lebree D. Clearance of atrial natriuretic peptide in patients with cirrhosis. Role of liver failure. J Hepatol 1991; 13: 351–7
   Google Scholar
• Ginès P, Jiménez W, Arroyo V, Navasa M, López C, Titó L. Atrial natriuretic factor in cirrhosis with ascites: Plasma levels cardiac release and splanchnic extraction. Hepatology 1988; 8: 636–42
   PubMed Web of Science ®Google Scholar
• Eiskjær H, Pedersen E B. Dose-response study of atrial natriuretic peptide bolus injection in healthy man. Eur J Clin Invest 1993; 23: 37–45
   PubMed Web of Science ®Google Scholar
• Janssen WMT, De Zeeuw D, Van der Hem G K, Jong P E. Atrial natriuretic peptide-induced decreases in renal blood flow in man: implications for the natriuretic mechanism. Clin Sci 1989; 77: 55–60
   Web of Science ®Google Scholar
• Leslie S H, Johnston B, Ralli E P. Renal function as a factor in fluid retention in patients with cirrhosis of the liver. J Clin Invest 1951; 30: 1200–7
   PubMedGoogle Scholar
• Wong F, Massie D, Colman J, Dudley F. Glomerular hyperfiltration in patients with well-compensated alcoholic cirrhosis. Gastroenterology 1993; 104: 884–9
   Google Scholar
• Mogensen C E, Sølling K, Vittinghus E. Studies on mechanisms of proteinuria using aminoacid-induced inhibition of tubular reabsorption in normal and diabetic man. Contr Nephrol 1981; 26: 50–65, Basle: Karger
   PubMedGoogle Scholar
• Badalamenti S, Ginés P, Arroyo V, Llach J, Piera C, Rimola A. Effects of intravenous amino acid infusion and dietary proteins on kidney function in cirrhosis. Hepatology 1990; 11: 379–86
   Google Scholar
• Calver A, Harris A, Maxwell D, Vallance P. Effect of local inhibition of nitric oxide synthesis on forearm blood flow and dorsal hand vein size in patients with alcoholic cirrhosis. Clin Sci 1994; 86: 203–8
   Google Scholar
• Biollaz J, Bidiville J, Diézi J, Waeber B, Nussberger J, Brunner-Ferber F. Site of the action of a synthetic atrial natriuretic peptide evaluated in humans. Kidney Int 1987; 32: 537–46
   PubMed Web of Science ®Google Scholar
• Rabelink T J, Koomans H A, De Stolpe A V, Bijlsma J A, Dorhout Mees E J. Effects of atrial natriuretic peptide on distal tubule function in humans. Kidney Int 1990; 37: 996–1001
   Google Scholar
• Eiskjær H, Sørensen S S, Danielsen H, Pedersen E B. Glomerular and tubular antinatriuretic actions of low dose angiotensin II infusion in man. J Hypertens 1992; 10: 1033–40
   Google Scholar
• Gerbes A L, Kollenda M C, Vollmar A M, Reichen J, Vakil N, Scarborough R M. Altered density of glomerular binding sites for atrial natriuretic factor in bile duct-ligated rats with ascites. Hepatology 1991; 13: 562–6
   Google Scholar
• Heim J-M, Gottmann K, Weil J, Haufe M C, Gerzer R. Is cyclic GMP a clinically useful marker for ANP action. Z Kardiol 1988; 77 Suppl 2: 41–6
   Google Scholar
• Waldman S A, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev 1987; 39: 163–96
   PubMed Web of Science ®Google Scholar
• Atherton J C, Green R, Hughes S, McFall V, Sharples J A, Solomon L R, Wilson L. Lithium clearance in man: effects of dietary salt intake, acute changes in extracellular fluid volume, amiloride and frusemide. Clin Sci 1987; 73: 645–51
   PubMed Web of Science ®Google Scholar
• Angeli P, De Bei E, Dalla Pria M, Caregaro L, Ceolotto G, Albino G. Effects of amiloride on renal lithium handling in nonazotemic ascitic patients with avid sodium retention. Hepatology 1992; 15: 651–654
   Google Scholar
• Sørensen S S, Madsen J K, Pedersen E B. Systemic and renal effect of intravenous infusion of endothelin-1 in healthy human volunteers. Am J Physiol 1994; 266: F411–18
   Google Scholar
• Kirchenbaum M A, Serros E R. Effects of alterations in urine flow rate on prostaglandin E excretions in concious dogs. Am J Physiol 1980; 238: F107, -F111
   Google Scholar
• Koepke J P, Jones S, Dibona G F. Renal nerves mediate blunted natriuresis to atrial natriuretic peptide in cirrhotic rats. Am J Physiol 1987; 252: R1019–23
   PubMedGoogle Scholar
• Morali G A, Floras J S, Legault L, Tobe S, Skorecki K L, Blendis L M. Muscle sympathetic nerve activity and renal responsiveness to atrial natriuretic factor during development of hepatic ascites. Am J Med 1991; 91: 383–92
   Google Scholar